Share on StockTwits

Henry Schein (NASDAQ:HSIC) Director Louis W. Sullivan sold 17,262 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $119.99, for a total transaction of $2,071,267.38. Following the sale, the director now directly owns 19,148 shares in the company, valued at approximately $2,297,569. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Henry Schein (NASDAQ:HSIC) traded up 0.11% during mid-day trading on Tuesday, hitting $119.82. The stock had a trading volume of 239,978 shares. Henry Schein has a one year low of $100.64 and a one year high of $120.99. The stock’s 50-day moving average is $118.2 and its 200-day moving average is $117.5. The company has a market cap of $10.165 billion and a P/E ratio of 23.05.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.35 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.33 by $0.02. The company had revenue of $2.60 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter last year, the company posted $1.23 earnings per share. Henry Schein’s revenue was up 9.3% compared to the same quarter last year. Analysts expect that Henry Schein will post $5.38 EPS for the current fiscal year.

A number of analysts have recently weighed in on HSIC shares. Analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note on Friday. They now have a $125.00 price target on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Henry Schein in a research note on Tuesday, August 5th. They now have a $121.00 price target on the stock, up previously from $120.00. Finally, analysts at Leerink Swann raised their price target on shares of Henry Schein from $120.00 to $127.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $123.60.

Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.

Receive News & Ratings for Henry Schein Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.